MYnd Analytics, Inc. Announces Appointment of Thomas Tierney to Board of Directors
October 04, 2016 08:00 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Oct. 04, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTC:QB CNSOD), which provides a unique set of reference data and analytic tools for clinicians to assist in...
MYnd Analytics Letter to Shareholders
September 21, 2016 08:05 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 21, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSO) To our shareholders: We appreciate your continued support. We have produced disruptive results for one...
MYnd Analytics Announces Conversion of Outstanding Notes Following Closing on Last Tranche of $6.0 Million Financing and Recapitalization Including a Reverse Stock Split and Elimination of 99% of Outstanding Warrants
September 20, 2016 18:03 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSO) today announced that a reverse split of the Company’s common stock, at a ratio of one share for every...
MYnd Analytics adds genomics to PEER Report, Building a “Gold-Standard” for evidence-based prescribing
May 26, 2016 09:00 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., May 26, 2016 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSO) has reached agreements with national laboratories to add genetic testing to its PEER Report. This...
Personalized Medicine and Autism Spectrum Disorder Conference in New York City
May 25, 2016 13:09 ET
|
ICare4Autism
NEW YORK, NY--(Marketwired - May 25, 2016) - The 2016 ICare4Autism National Autism Conference held on May 24th, 2016 at Montefiore Medical Center and Albert Einstein College of Medicine focused...
One-Third of Cancer Patients Have a Genetic Profile Accessible by Their Oncologist
May 25, 2016 11:00 ET
|
Industry Standard Research
CARY, NC --(Marketwired - May 25, 2016) - A new market research report titled Personalized Medicine's Effect on Oncologists' Treatment Regimens, from Industry Standard Research (ISR), finds that,...
CollabRx Chief Medical Officer to Moderate Panel at Personalized Medicine World Conference (PMWC) 2016
December 10, 2015 07:00 ET
|
CollabRx, Inc.
SAN FRANCISCO, Dec. 10, 2015 (GLOBE NEWSWIRE) -- CollabRx, Inc. a leading clinical decision support company and wholly owned subsidiary of Rennova Health, Inc. (NASDAQ:RNVA) today announced that its...
Coriell Institute's Precision Medicine Study Identifies Important Associations Between Genetics and Sleep Behavior
November 02, 2015 11:40 ET
|
Coriell Institute for Medical Research
CAMDEN, N.J., Nov. 2, 2015 (GLOBE NEWSWIRE) -- The Coriell Personalized Medicine Collaborative (CPMC), a research initiative exploring the utility of genetic information in the clinical setting, has...
Genomic Profiling Study Brings Personalized Medicine to Metastatic Bladder Cancer Patients
September 24, 2015 08:13 ET
|
Bladder Cancer Advocacy Network
BETHESDA, Md., Sept. 24, 2015 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder...
OncoMed Presents Biomarker-Focused Clinical Data From Phase 1a Trial of Anti-Notch1 (OMP-52M51) in Oral Plenary Session at the 26th EORTC-NCI-AACR Symposium
November 19, 2014 07:50 ET
|
OncoMed Pharmaceuticals, Inc.
BARCELONA, Spain and REDWOOD CITY, Calif., Nov. 19, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem...